MC
GMED icon

Muhlenkamp & Co’s Globus Medical GMED Stock Holding History

Muhlenkamp & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-51,480
Closed -$1.37M – 65
2014
Q1 		$1.37M Sell
51,480
-61,395
-54% -$1.46M 0.24% 49
2013
Q4 		$2.28M Buy
112,875
+19,070
+20% +$354K 0.4% 49
2013
Q3 		$1.64M Sell
93,805
-2,345
-2% -$40.6K 0.33% 44
2013
Q2 		$1.62M Buy
+96,150
New +$1.48M 0.34% 44

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CCM
Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Muhlenkamp & Co's GMED Position: Q2 2014 in Review

Muhlenkamp & Co sold out of Globus Medical (GMED) in Q2 2014, closing a stake of 51,480 shares — an estimated $1.37M sold.

Muhlenkamp & Co first reported a position in GMED in Q2 2013 and held it in 4 quarters. The position peaked at $2.28M in Q4 2013. 175 funds tracked by Wall St. Rank hold GMED as of Q2 2014.

  • Muhlenkamp & Co reported no remaining Globus Medical position as of Q2 2014 after selling out during the quarter.
  • Muhlenkamp & Co sold 51,480 Globus Medical shares in Q2 2014, an estimated $1.37M.
  • Muhlenkamp & Co first reported a position in Globus Medical in Q2 2013 and held it in 4 quarters.
  • Muhlenkamp & Co's Globus Medical position peaked at $2.28M in Q4 2013.
  • 175 funds tracked by Wall St. Rank held Globus Medical as of Q2 2014.

Based on Muhlenkamp & Co's 13F filing for Q2 2014, filed 14 Aug 2014.